Progress in Multiple Sclerosis Research: An Example of Bedside to Bench

JAMA. 2020 Sep 1;324(9):841-842. doi: 10.1001/jama.2020.1522.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology*
  • Central Nervous System / immunology
  • Disease Progression
  • Encephalomyelitis, Autoimmune, Experimental / pathology
  • Humans
  • Immunologic Factors / therapeutic use
  • Mice
  • Multiple Sclerosis / immunology*
  • Multiple Sclerosis / therapy*
  • Multiple Sclerosis, Chronic Progressive / immunology
  • Multiple Sclerosis, Chronic Progressive / therapy
  • Multiple Sclerosis, Relapsing-Remitting / immunology
  • Multiple Sclerosis, Relapsing-Remitting / therapy
  • Recurrence
  • Research Personnel
  • T-Lymphocytes
  • Translational Research, Biomedical*

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • ocrelizumab